Physician profile
Dane S Dycus
NPI 1861422875
$2,146.97
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,469 · 2020: $678.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $466.43 | 2019-2020 | |
| Lilly USA, LLC | $239.88 | 2019-2020 | |
| Allergan, INC. | $210.30 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.86 | 2019-2020 | |
| Astellas Pharma US INC | $169.79 | 2019-2020 | |
| Novo Nordisk INC | $146.13 | 2019-2020 | |
| Amarin Pharma, INC. | $132.68 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $111.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.29 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.28 | 2019 | |
| Zyla Life Sciences, INC. | $43.29 | 2019 | |
| Esperion Therapeutics, INC. | $37.02 | 2020 | |
| Arbor Pharmaceuticals, INC. | $29.65 | 2020 | |
| Pfizer INC. | $28.70 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.85 | 2019 | |
| Merck Sharp & Dohme LLC | $18.83 | 2020 | |
| Ironwood Pharmaceuticals, INC | $16.32 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.88 | 2020 | |
| Genentech USA, INC. | $13.63 | 2020 | |
| Eisai INC. | $12.04 | 2020 | |
| Nestle Healthcare Nutrition INC. | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Dycus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.